We also confirmed that there are consistent significant differences in myeloid versus adaptive immune cell infiltration into the tumour when considering the total cell population (rather than just the proportion of CD45+ cells) in both the Peng and Steele datasets (Supplementary Fig. 9f). The gene discussed is PTPRC; the disease is neoplasm.